tetano
Editor, Senior Moderator
Signal Transduct Target Ther
. 2021 Nov 15;6(1):396.
doi: 10.1038/s41392-021-00809-8.
The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong[SUP] #[/SUP][SUP] 1 [/SUP], Suideng Qin[SUP] #[/SUP][SUP] 2 [/SUP], Lunzhi Dai[SUP] 3 [/SUP], Zhixin Tian[SUP] 4 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19), a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more than 235 million individuals and led to more than 4.8 million deaths worldwide as of October 5 2021. Cryo-electron microscopy and topology show that the SARS-CoV-2 genome encodes lots of highly glycosylated proteins, such as spike (S), envelope (E), membrane (M), and ORF3a proteins, which are responsible for host recognition, penetration, binding, recycling and pathogenesis. Here we reviewed the detections, substrates, biological functions of the glycosylation in SARS-CoV-2 proteins as well as the human receptor ACE2, and also summarized the approved and undergoing SARS-CoV-2 therapeutics associated with glycosylation. This review may not only broad the understanding of viral glycobiology, but also provide key clues for the development of new preventive and therapeutic methodologies against SARS-CoV-2 and its variants.
. 2021 Nov 15;6(1):396.
doi: 10.1038/s41392-021-00809-8.
The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong[SUP] #[/SUP][SUP] 1 [/SUP], Suideng Qin[SUP] #[/SUP][SUP] 2 [/SUP], Lunzhi Dai[SUP] 3 [/SUP], Zhixin Tian[SUP] 4 [/SUP]
Affiliations
- PMID: 34782609
- DOI: 10.1038/s41392-021-00809-8
Abstract
Coronavirus disease 2019 (COVID-19), a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected more than 235 million individuals and led to more than 4.8 million deaths worldwide as of October 5 2021. Cryo-electron microscopy and topology show that the SARS-CoV-2 genome encodes lots of highly glycosylated proteins, such as spike (S), envelope (E), membrane (M), and ORF3a proteins, which are responsible for host recognition, penetration, binding, recycling and pathogenesis. Here we reviewed the detections, substrates, biological functions of the glycosylation in SARS-CoV-2 proteins as well as the human receptor ACE2, and also summarized the approved and undergoing SARS-CoV-2 therapeutics associated with glycosylation. This review may not only broad the understanding of viral glycobiology, but also provide key clues for the development of new preventive and therapeutic methodologies against SARS-CoV-2 and its variants.